Skip to main content

Advertisement

SpringerLink
Log in

Three Different Classifications, B Lymphocyte Subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) Gene Mutations, CTLA-4 and ICOS Gene Polymorphisms in Turkish Patients with Common Variable Immunodeficiency

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

B lymphocyte subpopulations, previously defined classification schemes (Freiburg, Paris, EuroClass), TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms were analyzed in 25 common variable immunodeficiency (CVID) patients and 25 healthy controls. Patients were also divided into two subgroups due to some disease severity criteria. SG (severe disease group) (n:11) included patients who have splenomegaly and/or granulomatous diseases and/or bronchiectasis and/or lower baseline IgG values (<270 mg/dl). MG (moderate disease group) (n:14) patients diagnosed as having ESID/PAGID criteria but does not fulfill SG inclusion criteria. The onset of infectious symptoms and age at diagnosis were 50.0 ± 45.7 and 78.5 ± 54.5 months, respectively. Parental consanguinity rate was 54.5% in SG and 7.1% in MG. Switched-memory B cells (CD19 + 27 + IgD-IgM-) showed significant decrease in CVID patients and these cells were also significantly lower in SG compared to MG. CVID patients had significantly higher percentages of CD19 + κ + B cells and CD19 + λ + B cells than healthy controls. Freiburg classification: 87,5% of patients (n:21) were in group I and 12.5% were in Group II. Eighteen (75%) CVID patients with a low percentage of CD21low B cells were in Group Ib while three patients classified as Group Ia. The significantly lower levels of IgG and IgA in Group Ia is a novel finding. The percentages of patients for Paris Classification groups MB0, MB1, MB2 were 88%, 4% and 8%, respectively. There was a significant increase of splenomegaly, lymphadenopathy and autoimmune cytopenia in Group MB0. EuroClass: 45.8% of patients were smB+ and 54.2% were smB-. Splenomegaly and lymphadenopathy were significantly higher in smB- group. TACI: One patient carried heterozygous C104R mutation which was known as disease causing. APRIL: G67R and N96S SNPs were detected in most of the patients and healthy controls. BAFF-R: P21R/H159Y compound heterozygous mutation (n:1) and P21R heterozygous mutations (n:3) were detected. +49 A > G changes in exon 1 of CTLA-4 gene: GG and AG genotypes increase the risk of CVID development 1.32 and 2.18 fold, respectively. 1564 T > C polymorphisms on 3′UTR region in exon 2 of ICOS gene was not found to be significantly different in CVID patients. CVID classifications were not helpful in determining the genetic etiology of CVID.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. BJH Review. 2009;145:709–27.

    Article  CAS  Google Scholar 

  2. Park MA, Li JT, Hugan JB, Muddox DE, Abraham RS. Common varible immunodeficiency: a new look at an old disease. Lancet. 2008;372:489–502.

    Article  PubMed  Google Scholar 

  3. Notarangelo LD. Primary Immunodeficiencies. J Allergy Clin Immunol. 2010;125:182–94.

    Article  Google Scholar 

  4. Pan-Hammarström Q, Hammarström L. Antibody deficiency diseases. Eur J Immunol. 2008;38:327–33.

    Article  PubMed  Google Scholar 

  5. Salzer U, Grimbacher B. Common variable immunodeficiency: the power of co-stimulation. Semin Immunol. 2006;18:337–46.

    Article  PubMed  CAS  Google Scholar 

  6. Vorechovsky I, Cullen M, Carrington M, Hammarström L, Webster AD. Fine mapping of IgAD1 in IgA deficiency and common variable immunodeficiency; identification and characterization of haplotypes shared by affected members of 101 multipl-case families. J Immunol. 2000;164:4408–16.

    PubMed  CAS  Google Scholar 

  7. Roifman CM, Rao CP, Lederman HM, Lavi S, Quinn P, Gelfand EW. Increased susceptibility to mycoplasma infection in patients with hypogammaglobulinemia. Am J Med. 1986;80:590–4.

    Article  PubMed  CAS  Google Scholar 

  8. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.

    Article  PubMed  CAS  Google Scholar 

  9. Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol. 2002;130:495–500.

    Article  PubMed  CAS  Google Scholar 

  10. Brandt D, Gershwin ME. Common variable immunodeficiency and autoimmunity. Autoimmun Rev. 2006;5:465–70.

    Article  PubMed  CAS  Google Scholar 

  11. Gathmann B, Binder N, Ehl S, Kindle G, The ESID. registry working party. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012;167:479–91.

    Article  PubMed  CAS  Google Scholar 

  12. Cunningham-Rundles C. Common variable immunodeficiency. Curr Allergy Asthma Rep. 2001;1:421–29.

    Article  PubMed  CAS  Google Scholar 

  13. Conley M, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiency). Clin Immunol. 1999;93:190–7.

    Article  PubMed  CAS  Google Scholar 

  14. Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, et al. Severe deficiency of switched memory B cells (CD27 + IgM-IgD-) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002;99:1544–51.

    Article  PubMed  CAS  Google Scholar 

  15. Moratto D, Gulino AV, Fontana S, Mori L, Pirovano S, Soresina A, et al. Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients. Clin Immunol. 2006;121:203–14.

    Article  PubMed  CAS  Google Scholar 

  16. Morimoto Y, Routes JM. Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep. 2005;8:370–5.

    Article  Google Scholar 

  17. Mouillot G, Carmagnat M, Gerard L, Garnier JL, Fieschi C, Vince N, et al. B cell and T cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol. 2010;30:746–55.

    Article  PubMed  Google Scholar 

  18. Kopecky O, Lukesova S. Genetic defects in common variable immunodeficiency. Int J Immunogenet. 2007;34:225–9.

    Article  PubMed  CAS  Google Scholar 

  19. Grimbacher B, Hutloff A, Schleiser M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4:261–8.

    Article  PubMed  CAS  Google Scholar 

  20. van Zelm MC, Reisli I, van der Burg M, et al. An antibody deficiency syndrome due to mutations in the CD19 gene. N Eng J Med. 2006;354:1901–12.

    Article  Google Scholar 

  21. Rivoisy C, Gerard L, Boutboul D, Malphettes M, Fieschi C, Durieu I, et al. Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency. J Clin Immunol. 2012;32:98–105.

    Article  PubMed  Google Scholar 

  22. Kuijpers TW, Bende RJ. Baars Pa, et al. CD20 deficiency in humans results in impaired T-cell independent antibody responses. J Clin Invest. 2010;120:214–22.

    Article  PubMed  CAS  Google Scholar 

  23. Van Zelm MC, Smet J, Adams B, et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest. 2010;120:1265–74.

    Article  PubMed  Google Scholar 

  24. Sanchez-Ramon S, Radigan L, Yu JE, Bard S, Cunningham-Rundles C. Memory B cells in common variable immunodeficiency: Clinical associations and sex differences. Clin Immunol. 2008;128:314–21.

    Article  PubMed  CAS  Google Scholar 

  25. Aksu G, Genel F, Koturoglu G, Kurugol Z, Kutukculer N. Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: a study using nephelometric technique. Turk J Pediatr. 2006;48:19–24.

    PubMed  Google Scholar 

  26. Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23:385–400.

    Article  PubMed  CAS  Google Scholar 

  27. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111:77–85.

    Article  PubMed  CAS  Google Scholar 

  28. Ikinciogullari A, Kendirli T, Dogu F, Egin Y, Reisli İ, Cin S, Babacan E. Peripheral blood lymphocyte subsets in healthy Turkish children. Turk J Pediatr. 2004;46:125–30.

    PubMed  Google Scholar 

  29. Spickett GP. Current perspectives on common variable immunodeficiency. Clin Exp Allergy. 2001;31:536–42.

    Article  PubMed  CAS  Google Scholar 

  30. Rezaei N, Aghamohammadi A, Moin A, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: Update from Iranian Primary Immunodeficiency registry. J Clin Immunol. 2006;26:519–32.

    Article  PubMed  Google Scholar 

  31. Edeer Karaca N, Gulez N, Aksu G, Kutukculer N. Common variable immunodeficiency: familial inheritance and autoimmune manifestations in two siblings. Turk J Pediatr. 2010;52:89–93.

    PubMed  Google Scholar 

  32. The French National registry of primary immunodeficiency diseases. Clin Immunol 2010; 135; 264–72.

    Google Scholar 

  33. Azarsiz E, Eder Karaca N, Gülez N, Aksu G, Kutukculer N. Consanguinity rate and delay in diagnosis in Turkish patients with combined immunodeficiency. J Clin Immunol. 2011;31:106–11.

    Article  PubMed  CAS  Google Scholar 

  34. Llobet MP, Soler-Palacin P, Detkova D, Hernandez M, Caragil I, Espanol T. Common variable immunodeficiency: 20-yr experience at a single center. Pediatr Allergy Immunol. 2009;20:113–8.

    Article  PubMed  Google Scholar 

  35. Sala Cunill A, Soler-Palacin P, Martin de Vicente C, Labrador Horrillo M, Luengo Sanchez O, Figueras Nadal C. Common variablee immunodeficiency. Prognostic factors for lung damage. Med Clin (Barc). 2010;134:64–7.

    Article  Google Scholar 

  36. Brandt D, Gershwin ME. Common variable immune deficiency and autoimmunity. Autoimmun Rev. 2006;5:465–70.

    Article  PubMed  CAS  Google Scholar 

  37. Kreuzaler M, Rauch M, Salzer U, Birmelin J, Rizzi M, Grimbacher B, Plebani A. J Immunol. 2012;188:497–503.

    Article  PubMed  CAS  Google Scholar 

  38. Alachkar H, Tauben Heim N, Haeney MR, Durandy A, Arkwright PD. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol. 2006;120:310–8.

    Article  PubMed  CAS  Google Scholar 

  39. Al Kindi M, Mundy J, Sullivan T, Smith W, Kette F, Smith A, Heddle R, Hissaria P. Utility of peripheral blood B cell subsets analysis in common variable immunodeficiency. Clin Exp Immunol. 2012;167:275–81.

    Article  PubMed  Google Scholar 

  40. Schatorje EJH, Gemen EFA, Driessen GJA, Leuvenink J, van Hout RWNM, van der Burg M, de Vries E. Age-matched reference values for B lymphocyte subpopulations and CVID classifications in children. Scand J Immunol. 2011;74:502–10.

    Article  PubMed  CAS  Google Scholar 

  41. Zhang M, Srivastava G, Lu L. The pre-B cell receptor ana its function during B cell development. Cell Mol Immunol. 2004;2:89–94.

    Google Scholar 

  42. Wang YH, Stephan RP, Scheffold A, et al. Differential surrogate light chains expressions governs B cell differentiation. Blood. 2002;99:2459–67.

    Article  PubMed  CAS  Google Scholar 

  43. Salzer U, Chapel HM, Webster AD, Pan-hammarström Q, Schmitt-Graeff A, Schleiser M, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005;37:820–8.

    Article  PubMed  CAS  Google Scholar 

  44. Castigli E, Wison SA, Garibyan L, Rachid R, Bonilla F, Schneider L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet. 2005;37:829–34.

    Article  PubMed  CAS  Google Scholar 

  45. Mohammadi J, Liu C, Aghamohammadi A, Bergbreiter A, Du L, Lu J, et al. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficency. J Clin Immunol. 2009;29:777–85.

    Article  PubMed  CAS  Google Scholar 

  46. Zhang L, Radigan L, Salzer U, Behrens TW, Grimbacher B, Diaz DG, et al. Transmembran activator ana calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: Clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol. 2007;120:1178–85.

    Article  PubMed  CAS  Google Scholar 

  47. Salzer U, Bacchelli C, Buckridge S, Pan-Hammarström Q, Jennings S, Lougaris V, et al. Relevance of biallelic versus monoallelic mutations in distinguishing disease causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood. 2009;113:1967–76.

    Article  PubMed  CAS  Google Scholar 

  48. Speletas M, Mamara A, Papadopoulou-Alataki E, Lordanakis G, Liadaki K, Bardaka F, Kanariou M, Germenis AE. TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies. J Clin Immunol. 2011;31:550–9.

    Article  PubMed  CAS  Google Scholar 

  49. Salzer U, Grimbacher B. TACItly changing tunes: farewell to a yin ana yang of BAFF receptor ana TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Curr Opinion in Allergy Clin Immunology. 2005;5:496–503.

    Article  CAS  Google Scholar 

  50. van de Ven AAJM, van de Corput L, van Tilburg CM, Tesselaar K, van Gent R, Sanders EAM, Boes M, Bloem AC, van Montfrans JM. Lymphocyte characteristics in children with common variable immunodeficiency. Clin Immunol. 2010;135:63–71.

    Article  PubMed  Google Scholar 

  51. Salzer U, Neumann C, Thiel J, Woelner C, Pan-Hammarström Q, Lougaris V, Hagena T, Jung J, Birmelin J, et al. Screening of functional and positional candidate genes in families with common variable immunodeficiency. BMC Immunol. 2008;9:1–9.

    Article  Google Scholar 

  52. Barroeta A, Cancrini C, Finocchi A, Conti F, La Rocca MA, Graziani S, Di Cesare S, et al. Molecular characterization of TNFRSF13B gene in pediatric patients with hypogammaglobulinemia. XIVth Meeting of the European Society for Immunodeficiencies (ESID) Abstract book, Istanbul, 2010, pp.84, poster 128.

  53. Mouillot G, Debre P, Oksenhendler E. Screening of the TNFRSF13C and ICOS genes in the DEFI study of adult patients with hypogammaglobulinemia. XIVth Meeting of the European Society for Immunodeficiencies (ESID) Abstract book, Istanbul, 2010, pp.87, poster 136.

  54. Speletas M, Mamara A, Bardaka F, Liadaki K, Argentou N, Tsitsami E, et al. BAFF-R deficiency due to TNFRSF13C-P21R homozygosity resulting in mild immunodeficiency syndrome. XIVth Meeting of the European Society for Immunodeficiencies (ESID) Abstract book, Istanbul, 2010, pp.86, poster 133.

  55. Yong PF, Salzer U, Grimbacher B. The role of co-stimulation in antibody deficiencies. ICOS and common variable immunodeficiency. Immunol Rev. 2009;229:101–13.

    Article  PubMed  CAS  Google Scholar 

  56. Salzer U, Maul-Pavicic A, Cunningham-Rundles C, Urschel S, Belohradsky BH, Litzman J, et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol. 2004;113:234–40.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

1)This research was partly funded by Dubai-Harvard Foundation Medical Research (DHFMR). We thank Dr. Raif Geha and Dr.Luigi D. Notarangelo for their excellent support.

2) Some of the medical records of our common variable immunodeficiency patients included in this study were obtained from ESID (European Society for Immunodeficiencies) Registry Database.

Author information

Authors and Affiliations

  1. Department of Pediatric Immunology, Ege University, Faculty of Medicine, 35100, Bornova, Izmir, Turkey

    Necil Kutukculer, Nesrin Gulez, Neslihan E. Karaca, Guzide Aksu & Afig Berdeli

Authors
  1. Necil Kutukculer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nesrin Gulez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neslihan E. Karaca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guzide Aksu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Afig Berdeli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Necil Kutukculer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kutukculer, N., Gulez, N., Karaca, N.E. et al. Three Different Classifications, B Lymphocyte Subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) Gene Mutations, CTLA-4 and ICOS Gene Polymorphisms in Turkish Patients with Common Variable Immunodeficiency. J Clin Immunol 32, 1165–1179 (2012). https://doi.org/10.1007/s10875-012-9717-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-012-9717-9

Keywords

Search

Navigation